Optometric Education Consultants
  • About OEC
  • Case Challenge
  • Conferences
    • Nashville ’25
    • Detroit ’25
    • Scottsdale ’26
    • Pittsburgh ’26
    • Sarasota ’26
    • Amsterdam ’26
    • Disney Resort ’26
    • Quebec ’26
    • Nashville ’26
    • Charleston Recap
    • All Conference Recaps
  • Webinars
  • Recorded Webinars
    Asynchronous
  • YouTube & Resources
Select Page

TQ Quiz | Glaucoma: What Would You Do? (Nashville 2024)

by Events@optometricedu.com | Sep 26, 2024 | 2024 Nashville, TQ Courses | 0 comments

"*" indicates required fields

This field is hidden when viewing the form
MM slash DD slash YYYY
This field is hidden when viewing the form
MM slash DD slash YYYY
This field is hidden when viewing the form
MM slash DD slash YYYY
This field is hidden when viewing the form
1. In the context of topical glaucoma medications, what is the most common definition of a “non-responder” to a particular glaucoma medication presented in this lecture?*
2. What is the approximate “failure rate” of prostaglandin analog medications?*
3. Based on what was presented in this lecture, which prostaglandin analog medication appears to have the largest percentage reduction in intraocular pressure (IOP)?*
4. Based solely on the small study presented in this lecture (Ford et al. in 2013), when is the best time of day to administer a prostaglandin analog medication?*
5. What is the approximate rate of clinically significant cystoid macular edema (CME) of patients on prostaglandin analog medications undergoing concurrent cataract surgery?*
6. What is best indicator on a standard 24-2 Humphrey automated visual field test that would strongly suggest the patient was not tested monocularly during the test?*
7. Based on the meta-analysis from 2010 (Tanna P, et al.) presented in lecture, which adjunct glaucoma medication class was least effective in additional IOP lowering efficacy?*
8. Based on the meta-analysis from 2013 (Budengeri P, et al.) presented in lecture, which combination glaucoma medication was statistically superior in regards to IOP lowering?*
9. What percentage of patients report good compliance with their glaucoma drops?*
10. Based on Greenberg’s study on patient compliance rates from 1984, what is the compliance rate of patients on one glaucoma medication?*
11. Based on Greenberg’s study on patient compliance rates from 1984, how much does compliance decrease when a patient goes from 1 glaucoma medication to 2 glaucoma medications?*
12. Based on the Ocular Hypertenstion Treatment Study (OHTS), which of the following patients has the highest risk of developing glaucoma over the next 5 years?*
13. Based on the data presented in lecture from 2021, what is the average life expectancy in the United States for males?*
14. Based on the data presented in lecture from 2021, what is the average life expectancy in the United States for females?*
15. What is the difference between using OCT and ultrasound probes when measuring central corneal thickness?*
16. Based on Jay et al. in 1993, what is the estimated average time from earliest glaucoma VF defect/loss to advanced glaucoma in a patient with uncontrolled IOP’s of 23 mmHg OU?*
17. Based on Jay et al. in 1993, what is the estimated average time from earliest glaucoma visual field defect/loss to advanced glaucoma in a patient with uncontrolled IOP’s of 33 mmHg OU?*
18. How often are disc hemorrhages associated with retinal nerve fiber layer defects in glaucoma?*
19. What is the most common location of disc hemorrhages associated with glaucoma to occur near or on the optic nerve?*
20. What is the first thing you should look at on any additional diagnostic testing for glaucoma patients?*

Personal Information

Name*
Address*

Payment Information

After 11/29/2024, pricing will increase to $30.
This course was presented over 60 days ago. Due to this late submission of TQ, your TQ credit price is $30.
This field is hidden when viewing the form

Course Information (HIDDEN)

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
Do not include ending backslash (aka no .com/)
This field is hidden when viewing the form

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Upcoming Conferences

Ready to get away this summer or fall. View our upcoming conferences and register today!

View

Case Challenges

Case Challenges

View our library of case challenges and share your comments or questions in the comment box below!

Learn More
For questions and more information, please contact us at events@optometricedu.com

Like and follow us on Facebook, Twitter, and Instagram for conference updates!

Subscribe For Event Updates

* indicates required